A novel strategy to target a genetic anomaly that occurs in half of all prostate cancers may provide a path for developing new therapies against it.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Comprehensive Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined the University of Michigan Health System in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
Black and Hispanic women are less likely to receive guideline-based care, especially at high-volume hospitals, according to a new analysis.
A protein in the tumor microenvironment plays a role in fueling cancer’s spread, a function that could potentially be blocked, according to a new study.
A new study finds exceptional long-term survival when a single dose of chemotherapy selects patients for chemoradiation or surgery.
A new study finds these side effects cause an extra burden for both patients and the health care system.
New research finds the protein PDX1 is critical for cancer growth, but blocking it may lead to more aggressive tumors.